Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index

被引:9
|
作者
Lee, Guy Mok [1 ]
Kim, Youe Ree [1 ]
Ryu, Jong Hyun [3 ]
Kim, Tae-Hoon [3 ]
Cho, Eun Young [2 ]
Lee, Young Hwan [1 ]
Yoon, Kwon-Ha [1 ,3 ]
机构
[1] Wonkwang Univ, Sch Med, Dept Radiol, 460 Iksan Daero, Iksan 54538, South Korea
[2] Wonkwang Univ, Sch Med, Dept Internal Med, Iksan 54538, South Korea
[3] Wonkwang Univ, Imaging Sci Res Ctr, Iksan 54538, South Korea
关键词
Liver; Magnetic resonance imaging; Chronic hepatitis B; Fibrosis; Gadoxetic acid; Gd-EOB-DTPA; ORGANIC ANION TRANSPORTERS; CONJUGATE EXPORT PUMP; LIVER FIBROSIS; PARENCHYMAL ENHANCEMENT; VIRUS INFECTION; ARTERIAL-PHASE; CIRRHOSIS; PREDICT; ELASTOGRAPHY; CHOLESTASIS;
D O I
10.3348/kjr.2017.18.3.444
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To quantitatively measure hepatic fibrosis on gadoxetic acid-enhanced magnetic resonance (MR) in chronic hepatitis B (CHB) patients and identify the correlations with aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis-4 index (FIB-4) values. Materials and Methods: This study on gadoxetic acid-enhanced 3T MR imaging included 81 patients with CHB infection. To quantitatively measure hepatic fibrosis, MR images were analyzed with an aim to identify inhomogeneous signal intensities calculated from a coefficient of variation (CV) map in the liver parenchyma. We also carried out a comparative analysis between APRI and FIB-4 based on metaregression results. The diagnostic performance of the CV map was evaluated using a receiver-operating characteristic (ROC) curve. Results: In the MR images, the mean CV values in control, groups I, II, and III based on APRI were 4.08 +/- 0.92, 4.24 +/- 0.80, 5.64 +/- 1.11, and 5.73 +/- 1.28, respectively (p < 0.001). In CHB patients grouped by FIB-4, the mean CV values of groups A, B, and C were 4.22 +/- 0.95, 5.40 +/- 1.19, and 5.71 +/- 1.17, respectively (p < 0.001). The mean CV values correlated well with APRI (r = 0.392, p < 0.001) and FIB-4 (r = 0.294, p < 0.001). In significant fibrosis group, ROC curve analysis yielded an area under the curve of 0.875 using APRI and 0.831 using FIB-4 in HB, respectively. Conclusion: Gadoxetic acid-enhanced MR imaging for calculating a CV map showed moderate correlation with APRI and FIB-4 values and could be employed to quantitatively measure hepatic fibrosis in patients with CHB.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 50 条
  • [1] Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis
    Dong, Bingtian
    Chen, Yuping
    Lyu, Guorong
    Yang, Xiaocen
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Efficacy of aspartate aminotransferase to platelet ratio index (APRI) on prediction of hepatic fibrosis in chronic hepatitis B
    Shin, Woon Geon
    Jang, Myoung Kuk
    Park, Sang Hoon
    Jun, Sun-Young
    Kim, Kyung Ho
    Park, Joon Yong
    Lee, Jin Heon
    Kim, Hak Yang
    GASTROENTEROLOGY, 2007, 132 (04) : A763 - A763
  • [3] Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid-enhanced MRI: Comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4
    Yang, Li
    Ding, Ying
    Rao, Shengxiang
    Chen, Caizhong
    Wu, Lifang
    Sheng, Ruofan
    Fu, Caixia
    Zeng, Mengsu
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2017, 45 (04) : 1186 - 1194
  • [4] Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index
    Motosugi, Utaroh
    Ichikawa, Tomoaki
    Oguri, Mitsuhiko
    Sano, Katsuhiro
    Sou, Hironobu
    Muhi, Ali
    Matsuda, Masanori
    Fujii, Hideki
    Enomoto, Nobuyuki
    Araki, Tsutomu
    MAGNETIC RESONANCE IMAGING, 2011, 29 (08) : 1047 - 1052
  • [5] Aspartate aminotransferase to platelet ratio index for the evaluation of fibrosis in chronic viral hepatitis
    Yetkin, M. A.
    Bulut, C.
    Caydere, M.
    Erdinc, F. S.
    Ertem, G.
    Kinikli, S.
    Tuelek, N.
    Uestuen, H.
    Demiroz, A. P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S538 - S538
  • [6] Aspartate aminotransferase to platelet ratio index for the evaluation of fibrosis in chronic viral hepatitis
    Aghasadeghi, M.
    Sadat, M.
    Khabiri, A.
    Rouhvand, F.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S538 - S538
  • [7] Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis
    Chrysanthos, Nikolaos V.
    Papatheodoridis, George V.
    Savvas, Savvas
    Kafiri, Georgia
    Petraki, Kalliopi
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (04) : 389 - 396
  • [8] Comparison of Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Adult Patients With Chronic Hepatitis B Virus Infection: A Systemic Review and Meta-analysis
    Xiao, Guangqin
    Yang, Jiayin
    Yan, Lunan
    HEPATOLOGY, 2015, 61 (01) : 292 - 302
  • [9] Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C
    Cheng, Chun-Han
    Chu, Chia-Ying
    Chen, Huan-Lin
    Lin, I-Tsung
    Wu, Chia-Hsien
    Lee, Yuan-Kai
    Hu, Ping-Jen
    Bair, Ming-Jong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (04) : 542 - 549
  • [10] Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
    Sirli, Roxana
    Sporea, Ioan
    HEPATITIS MONTHLY, 2011, 11 (07) : 560 - 561